Professor (Emeritus) A Barry Kay

Publications


Journals

  • Corrigan CJ; Wang W; Meng Q; Fang CL; Eid G; Caballero MR; Lv Z; An YQ; et alWang YH; Liu YJ; Kay AB; Lee TH; Ying S. (Jul 2011). Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J ALLERGY CLIN IMMUN. 128:116-124. DOI.
  • Worm M; Lee HH; Kleine-Tebbe J; Hafner RP; Laidler P; Healey D; Buhot C; Verhoef A; et alMaillere B; Kay AB; Larche M. (Jan 2011). Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergy. J ALLERGY CLIN IMMUN. 127:89-U169. DOI.
  • Kay AB. (Jan 2011). Calcitonin gene-related peptide- and vascular endothelial growth factor-positive inflammatory cells in late-phase allergic skin reactions in atopic subjects. J Allergy Clin Immunol. 127:232-237. DOI.
  • Bonner K; Kariyawasam HH; Ali FR; Clark P; Kay AB. (Dec 2010). Expression of functional receptor activity modifying protein 1 by airway epithelial cells with dysregulation in asthma. J Allergy Clin Immunol. 126:1277-83.e3. DOI.
  • Pegorier S; Campbell GA; Kay AB; Lloyd CM. (2010). Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir Res. 11:85. DOI.
  • Kariyawasam HH; Pegorier S; Barkans J; Xanthou G; Aizen M; Ying S; Kay AB; Lloyd CM; et alRobinson DS. (Sep 2009). Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma. J Allergy Clin Immunol. 124:454-462. DOI.
  • Semitekolou M; Alissafi T; Aggelakopoulou M; Kourepini E; Kariyawasam HH; Kay AB; Robinson DS; Lloyd CM; et alPanoutsakopoulou V; Xanthou G. (3 Aug 2009). Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J EXP MED. 206:1769-1785. DOI.
  • Campbell JD; Buckland KF; McMillan SJ; Kearley J; Oldfield WLG; Stern LJ; Gronlund H; van Hage M; et alReynolds CJ; Boyton RJ; Cobbold SP; Kay AB; Altmann DM; Lloyd CM; Larche M. (6 Jul 2009). Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J EXP MED. 206:1535-1547. DOI.
  • Corrigan CJ; Jayaratnam A; Wang Y; Liu Y; Malefyt RD; Meng Q; Kay AB; Phipps S; et alLee TH; Ying S. (Jul 2009). Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects. ALLERGY. 64:1014-1022. DOI.
  • Gaga M; Ong YE; Benyahia F; Aizen M; Barkans J; Kay AB. (Jun 2008). Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha. Allergy. 63:703-711. DOI.
  • Kariyawasam HH; Xanthou G; Barkans J; Aizen M; Kay AB; Robinson DS. (15 May 2008). Basal expression of bone morphogenetic protein receptor is reduced in mild asthma. AM J RESP CRIT CARE. 177:1074-1081. DOI.
  • Kay AB. (Dec 2007). An extract of timothy-grass pollen used as sublingual immunotherapy for summer hay fever. DRUG TODAY. 43:841-848. DOI.
  • Ali FR; Kay AB; Larche M. (Sep 2007). Airway hyperresponsiveness and bronchial mucosal inflammation in T cell peptide-induced asthmatic reactions in atopic subjects. THORAX. 62:750-757. DOI.
  • Menzies-Gow AN; Flood-Page PT; Robinson DS; Kay AB. (Jul 2007). Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers. Clin Exp Allergy. 37:1023-1032. DOI.
  • Kariyawasam HH; Aizen M; Kay AB; Robinson DS. (Jun 2007). Safety and tolerability of three consecutive bronchoscopies after allergen challenge in volunteers with mild asthma. THORAX. 62:557-558. DOI.
  • Kay AB; Ali FR; Heaney LG; Benyahia F; Soh CP; Renz H; Lee TH; Larché M. (May 2007). Airway expression of calcitonin gene-related peptide in T-cell peptide-induced late asthmatic reactions in atopics. Allergy. 62:495-503. DOI.
  • Kariyawasam HH; Aizen M; Barkans J; Robinson DS; Kay AB. (1 May 2007). Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma. Am J Respir Crit Care Med. 175:896-904. DOI.
  • Kay AB. (May 2006). 100 years of 'Allergy': can von Pirquet's word be rescued?. Clin Exp Allergy. 36:555-559. DOI.
  • Tarzi M; Klunker S; Texier C; Verhoef A; Stapel SO; Akdis CA; Maillere B; Kay AB; et alLarche M. (Apr 2006). Induction of interleukin-10 and suppressor of cytokine signalling-3 gene expression following peptide immunotherapy. CLIN EXP ALLERGY. 36:465-474.
  • Kay AB. (16 Mar 2006). Natural killer T cells and asthma. NEW ENGL J MED. 354:1186-1188.
  • Alexander C; Tarzi M; Larché M; Kay AB. (Oct 2005). The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects. Allergy. 60:1269-1274. DOI.
  • Ong YE; Menzies-Gow A; Barkans J; Benyahia F; Ou TT; Ying S; Kay AB. (Sep 2005). Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge. J Allergy Clin Immunol. 116:558-564. DOI.
  • Kay AB. (Apr 2005). The role of eosinophils in the pathogenesis of asthma. Trends Mol Med. 11:148-152. DOI.
  • Verhoef A; Alexander C; Kay AB; Larche M. (Mar 2005). T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLOS MED. 2:253-261. DOI.
  • Alexander C; Ying S; Kay AB; Larche M. (Jan 2005). Fel d 1-derived T cell peptide therapy induces recruitment of CD4(+)CD25(+); CD4(+) interferon-gamma(+) T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects. CLIN EXP ALLERGY. 35:52-58. DOI.
  • Phipps S; Benyahia F; Ou TT; Barkans J; Robinson DS; Kay AB. (Dec 2004). Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol. 31:626-632. DOI.
  • Kay AB; Klion AD. (Nov 2004). Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome. Immunol Allergy Clin North Am. 24:645-vii. DOI.
  • Smith TR; Alexander C; Kay AB; Larché M; Robinson DS. (Oct 2004). Cat allergen peptide immunotherapy reduces CD4(+) T cell responses to cat allergen but does not alter suppression by CD4(+) CD25(+) T cells: a double-blind placebo-controlled study. Allergy. 59:1097-1101. DOI.
  • Kay AB; Phipps S; Robinson DS. (Sep 2004). A role for eosinophils in airway remodelling in asthma. Trends Immunol. 25:477-482. DOI.
  • Menzies-Gow A; Ying S; Phipps S; Kay AB. (Aug 2004). Interactions between eotaxin, histamine and mast cells in early microvascular events associated with eosinophil recruitment to the site of allergic skin reactions in humans. Clin Exp Allergy. 34:1276-1282. DOI.
  • Phipps S; Flood-Page P; Menzies-Gow A; Ong YE; Kay AB. (Jun 2004). Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. J Invest Dermatol. 122:1406-1412. DOI.
  • Kay AB; Larché M. (Feb 2004). Allergen immunotherapy with cat allergen peptides. Springer Semin Immunopathol. 25:391-399. DOI.
  • Ali FR; Oldfield WL; Higashi N; Larché M; Kay AB. (1 Jan 2004). Late asthmatic reactions induced by inhalation of allergen-derived T cell peptides. Am J Respir Crit Care Med. 169:20-26. DOI.
  • Flood-Page P; Menzies-Gow A; Phipps S; Ying S; Wangoo A; Ludwig MS; Barnes N; Robinson D; et alKay AB. (Oct 2003). Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest. 112:1029-1036. DOI.
  • Sehmi R; Dorman S; Baatjes A; Watson R; Foley R; Ying S; Robinson DS; Kay AB; et alO'Byrne PM; Denburg JA. (Aug 2003). Allergin-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34(+) cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. IMMUNOLOGY. 109:536-546.
  • Ying S; Khan LN; Meng Q; Barnes NC; Kay AB. (Aug 2003). Cyclosporin A, apoptosis of BAL T-cells and expression of Bcl-2 in asthmatics. Eur Respir J. 22:207-212.
  • Kay AB; Menzies-Gow A. (15 Jun 2003). Eosinophils and interleukin-5 - The debate continues. AM J RESP CRIT CARE. 167:1586-1587. DOI.
  • Kay AB. (Jun 2003). Immunomodulation in asthma: mechanisms and possible pitfalls. Curr Opin Pharmacol. 3:220-226.
  • Menzies-Gow A; Flood-Page P; Sehmi R; Burman J; Hamid Q; Robinson DS; Kay AB; Denburg J. (Apr 2003). Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol. 111:714-719.
  • Larché M; Robinson DS; Kay AB. (Mar 2003). The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol. 111:450-463.
  • Flood-Page PT; Menzies-Gow AN; Kay AB; Robinson DS. (15 Jan 2003). Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med. 167:199-204. DOI.
  • Phipps S; Ying S; Wangoo A; Ong YE; Levi-Schaffer F; Kay AB. (15 Oct 2002). The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol. 169:4604-4612.
  • Menzies-Gow A; Ying S; Sabroe I; Stubbs VL; Soler D; Williams TJ; Kay AB. (1 Sep 2002). Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J Immunol. 169:2712-2718.
  • Oldfield WL; Larché M; Kay AB. (6 Jul 2002). Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet. 360:47-53.
  • Ying S; Meng Q; Kay AB; Robinson DS. (Jun 2002). Elevated expression of interleukin-9 mRNA in the bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy. 32:866-871.
  • Ying S; Kikuchi Y; Meng Q; Kay AB; Kaplan AP. (Apr 2002). TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 109:694-700.
  • Ali FR; Kay AB; Larché M. (Mar 2002). The potential of peptide immunotherapy in allergy and asthma. Curr Allergy Asthma Rep. 2:151-158.
  • Robinson DS; Kay AB; Wardlaw AJ. (2002). Eosinophils. Clin Allergy Immunol. 16:43-75.
  • Ying S; Meng Q; Smith SJ; Larche M; Robinson DS; Kay AB. (2002). Methods for identifying human eosinophils in blood and tissue. ACI International. 2, 14:64-71.
  • Nasser SM; Ying S; Meng Q; Kay AB; Ewan PW. (Dec 2001). Interleukin-10 levels increase in cutaneous biopsies of patients undergoing wasp venom immunotherapy. Eur J Immunol. 31:3704-3713. DOI.
  • Ying S; Meng Q; Barata LT; Kay AB. (Nov 2001). Macrophage inflammatory protein-1alpha and C-C chemokine receptor-1 in allergen-induced skin late-phase reactions: relationship to macrophages, neutrophils, basophils, eosinophils and T lymphocytes. Clin Exp Allergy. 31:1724-1731.
  • Haselden BM; Larché M; Meng Q; Shirley K; Dworski R; Kaplan AP; Bates C; Robinson DS; et alYing S; Kay AB. (Sep 2001). Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol. 108:394-401. DOI.
  • Haselden BM; Syrigou E; Jones M; Huston D; Ichikawa K; Chapman MD; Kay AB; Larché M. (Sep 2001). Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1. J Allergy Clin Immunol. 108:349-356. DOI.
  • Oldfield WL; Kay AB; Larché M. (1 Aug 2001). Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol. 167:1734-1739.
  • Kon OM; Sihra BS; Loh LC; Barkans J; Compton CH; Barnes NC; Larché M; Kay AB. (Jul 2001). The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma. Eur Respir J. 18:45-52.
  • Ying S; Humbert M; Meng Q; Pfister R; Menz G; Gould HJ; Kay AB; Durham SR. (Apr 2001). Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol. 107:686-692.
  • Kay AB. (11 Jan 2001). Allergy and allergic diseases. Second of two parts. N Engl J Med. 344:109-113. DOI.
  • Kay AB. (4 Jan 2001). Allergy and allergic diseases. First of two parts. N Engl J Med. 344:30-37. DOI.
  • Powell N; Till SJ; Kay AB; Corrigan CJ. (Jan 2001). The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein. Clin Exp Allergy. 31:69-76.
  • Zeibecoglou K; Ying S; Meng Q; Kay AB; Robinson DS; Papageorgiou N. (Nov 2000). Expression of eotaxin in induced sputum of atopic and nonatopic asthmatics. Allergy. 55:1042-1048.
  • Khan LN; Kon OM; Macfarlane AJ; Meng Q; Ying S; Barnes NC; Kay AB. (Oct 2000). Attenuation of the allergen-induced late asthmatic reaction by cyclosporin A is associated with inhibition of bronchial eosinophils, interleukin-5, granulocyte macrophage colony-stimulating factor, and eotaxin. Am J Respir Crit Care Med. 162:1377-1382.
  • Zeibecoglou K; Ying S; Meng Q; Poulter LW; Robinson DS; Kay AB. (Oct 2000). Macrophage subpopulations and macrophage-derived cytokines in sputum of atopic and nonatopic asthmatic subjects and atopic and normal control subjects. J Allergy Clin Immunol. 106:697-704. DOI.
  • Macfarlane AJ; Dworski R; Sheller JR; Pavord ID; Kay AB; Barnes NC. (May 2000). Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. AM J RESP CRIT CARE. 161:1553-1558.
  • Tavernier J; Van der Heyden J; Verhee A; Brusselle G; Van Ostade X; Vandekerckhove J; North J; Rankin SM; et alKay AB; Robinson DS. (1 Mar 2000). Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. BLOOD. 95:1600-1607.
  • Smith SJ; Ying S; Meng Q; Sullivan MH; Barkans J; Kon OM; Sihra B; Larché M; et alLevi-Schaffer F; Kay AB. (Feb 2000). Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein. J Allergy Clin Immunol. 105:309-317.
  • Macfarlane AJ; Kon OM; Smith SJ; Zeibecoglou K; Khan LN; Barata LT; McEuen AR; Buckley MG; et alWalls AF; Meng Q; Humbert M; Barnes NC; Robinson DS; Ying S; Kay AB. (Jan 2000). Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol. 105:99-107.
  • Smith SJ; Ying S; Meng Q; Sullivan MHF; Barkans J; Kon OM; Sihra B; LarchE M; et alLevi-Schaffer F; Kay AB. (Jan 2000). Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, gamma*, and gamma* subunits of the high affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein. J ALLERGY CLIN IMMUN. 105:S253-S253.
  • Zeibecoglou K; King S; Meng Q; Poulter LW; Robinson DS; Kay AB. (Jan 2000). Interleukin-12 and IL-10 expression in the induced sputum of atopic asthmatics, atopic non-asthmatics, atopic, and normal controls. J ALLERGY CLIN IMMUN. 105:S281-S281.
  • Kay AB. (2000). Overview of 'allergy and allergic diseases: with a view to the future'. Br Med Bull. 56:843-864.
  • Ying S; Meng Q; Zeibecoglou K; Robinson DS; Macfarlane A; Humbert M; Kay AB. (1 Dec 1999). Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol. 163:6321-6329.
  • Durham SR; Varney VA; Gaga M; Jacobson MR; Varga EM; Frew AJ; Kay AB. (Nov 1999). Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy. 29:1490-1496.
  • Humbert M; Menz G; Ying S; Corrigan CJ; Robinson DS; Durham SR; Kay AB. (Nov 1999). The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. IMMUNOL TODAY. 20:528-533.
  • Kon OM; Kay AB. (Oct 1999). Anti-T cell strategies in asthma. Inflamm Res. 48:516-523.
  • Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; et alKay AB. (1 Oct 1999). C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol. 163:3976-3984.
  • Jacobson MR; Juliusson S; Löwhagen O; Balder B; Kay AB; Durham SR. (Oct 1999). Effect of topical corticosteroids on seasonal increases in epithelial eosinophils and mast cells in allergic rhinitis: a comparison of nasal brush and biopsy methods. Clin Exp Allergy. 29:1347-1355.
  • Zeibecoglou K; Macfarlane AJ; Ying S; Meng Q; Pavord I; Barnes NC; Robinson DS; Kay AB. (Jul 1999). Increases in eotaxin-positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge. Allergy. 54:730-735.
  • Haselden BM; Kay AB; Larché M. (21 Jun 1999). Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med. 189:1885-1894.
  • Macfarlane AJ; Pavord ID; Dworski R; Sheller JR; Kay AB; Barnes NC. (Mar 1999). Enhanced cysteinyl. leukotriene but not prostanoid expression in induced sputum due to allergen inhalational. AM J RESP CRIT CARE. 159:A849-A849.
  • Robinson DS; North J; Zeibecoglou K; Ying S; Meng Q; Rankin S; Hamid Q; Tavernier J; et alKay AB. (Feb 1999). Eosinophil development and bone marrow and tissue eosinophils in atopic asthma. Int Arch Allergy Immunol. 118:98-100.
  • Kon OM; Kay AB. (Feb 1999). T cells and chronic asthma. Int Arch Allergy Immunol. 118:133-135.
  • Robinson DS; Kay AB. (1999). Allergy. IMMUNOLOGIST. 7:51-53.
  • Ying S; Meng Q; Robinson DS; Zeibecoglou K; Humbert M; Kay AB. (Jan 1999). Bronchial mucosal expression of CC chemokines eotaxin, eotaxin-2, MCP-4, MCP-3 and RANTES and their receptor CCR3 in atopic asthmatics, non-atopic asthmatics, atopic controls and normal controls: Relationship of infiltration of eosinophils. J ALLERGY CLIN IMMUN. 103:S47-S47.
  • Robinson DS; Damia R; Zeibecoglou K; Molet S; North J; Yamada T; Kay AB; Hamid Q. (Jan 1999). CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol. 20:9-13.
  • Barkans J; Meng Q; Jose PJ; Smith S; Williams TJ; Robinson DS; Kay AB; Ying S. (Jan 1999). Effects of cytokines on eotaxin production by human endothelial cell line and human umbilical vein endothelial cells (HUVEC). J ALLERGY CLIN IMMUN. 103:S48-S48.
  • Macfarlane AJ; Zeibecoglou K; Khan N; Haselden BM; Ying S; Robinson DS; McEuen AR; Buckley MG; et alWalls AF; Barnes NC; Kay AB. (Jan 1999). Elevated numbers of basophils in baseline atopic asthma (AA) compared to rhinitic (AR) and normal controls (NC), and after allergen challenge. J ALLERGY CLIN IMMUN. 103:S192-S192.
  • Zeibecoglou K; Ying S; Meng Q; Papageorgiou N; Robinson DS; Kay AB. (Jan 1999). Eotaxin and eotaxin-2 expression in the induced sputum of atopic asthmatics (AA), non-atopic asthmatics (NAA) atopic Controls (AC), and normal controls (NC). J ALLERGY CLIN IMMUN. 103:S230-S230.
  • Zeibecoglou K; Ying S; Yamada T; North J; Burman J; Bungre J; Meng Q; Kay AB; et alRobinson DS. (Jan 1999). Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and nonatopic control subjects. J Allergy Clin Immunol. 103:99-106.
  • Robinson DS; North J; Rankin S; Kay AB; Van ostade X; Van der Heyden J; Brusselle G; Vanderkerckhove J; et alVerhee A; Tavernier J. (Jan 1999). Interleukin-5 regulates the isoform expression of its own receptor alpha-subunit. J ALLERGY CLIN IMMUN. 103:S238-S238.
  • Haselden BM; Syrigou E; North J; Jones M; Huston D; Ichikawa K; Chapman MD; Kay AB; et alLarche M. (Jan 1999). Intramolecular variation in cytokine production profiles in allergic asthma: A comparison of allergen peptide-specific responses in defined clinical groups. J ALLERGY CLIN IMMUN. 103:S230-S230.
  • Meng Q; Ying S; Robinson DS; McEuen AR; Buckley MG; Walls A; Barata LT; Kay AB. (Jan 1999). Kinetic expression of mRNA for CC chemokines eotaxin, eotaxin-2, MCP-4, MCP-3 and RANTES and their receptor CCR3 in allergen induced skin late phase reactions (LPR): Relationship of infiltration of eosinophils and basophils. J ALLERGY CLIN IMMUN. 103:S54-S54.
  • Kay AB; Meng Q; Barkans J; MacFarlane A; Gilmour J; Lee TH; Robinson DS; Ying S. (Jan 1999). Leukotrienes (LT) C-4, D-4, E-4 and histamine induce eotaxin expression by human endothelial cell line and human umbilical vein endothelial cells (HUVEC). J ALLERGY CLIN IMMUN. 103:S203-S203.
  • Larche M; Haselden BM; Kay AB. (Jan 1999). Peptide-induced late asthmatic reactions following MHC-restricted T cell activation in vitro. J ALLERGY CLIN IMMUN. 103:S204-S204.
  • Khan LN; Ying S; Macfarlane AJ; Barnes NC; Kay AB. (Jan 1999). The effect of cyclosporin A (CsA) on allergen-induced infiltration of EG2+ eosinophils, BB1+ basophils and eotaxin+ cells in bronchial biopsies from mild atopic asthmatics. J ALLERGY CLIN IMMUN. 103:S47-S47.
  • Larché M; Till SJ; Haselden BM; North J; Barkans J; Corrigan CJ; Kay AB; Robinson DS. (1 Dec 1998). Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol. 161:6375-6382.
  • Kon OM; Sihra BS; Compton CH; Leonard TB; Kay AB; Barnes NC. (3 Oct 1998). Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. LANCET. 352:1109-1113.
  • Masuyama K; Till SJ; Jacobson MR; Kamil A; Cameron L; Juliusson S; Lowhagen O; Kay AB; et alHamid QA; Durham SR. (Oct 1998). Nasal eosinophilia and IL-5 mRNA expression in seasonal allergic rhinitis induced by natural allergen exposure: effect of topical corticosteroids. J Allergy Clin Immunol. 102:610-617.
  • Kon OM; Sihra BS; Till SJ; Corrigan CJ; Kay AB; Grant JA. (Sep 1998). Unstimulated basophils in atopic and nonatopic subjects express intracellular interleukin-4: detection by flow cytometry. Allergy. 53:891-896.
  • Till SJ; Durham SR; Rajakulasingam K; Humbert M; Huston D; Dickason R; Kay AB; Corrigan CJ. (Aug 1998). Allergen-induced proliferation and interleukin-5 production by bronchoalveolar lavage and blood T cells after segmental allergen challenge. Am J Respir Crit Care Med. 158:404-411.
  • Gaga M; Bentley AM; Humbert M; Barkans J; O'Brien F; Wathen CG; Kay AB; Durham SR. (Aug 1998). Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax. 53:685-691.
  • Rajakulasingam K; Till S; Ying S; Humbert M; Barkans J; Sullivan M; Meng Q; Corrigan CJ; et alBungre J; Grant JA; Kay AB; Durham SR. (Jul 1998). Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma. Am J Respir Crit Care Med. 158:233-240.
  • Yamada T; Sun Q; Zeibecoglou K; Bungre J; North J; Kay AB; Lopez AF; Robinson DS. (May 1998). IL-3, IL-5, granulocyte-macrophage colony-stimulating factor receptor alpha-subunit, and common beta-subunit expression by peripheral leukocytes and blood dendritic cells. J Allergy Clin Immunol. 101:677-682. DOI.
  • Kay AB; Barnes NC. (28 Feb 1998). Non-steroidal anti-inflammatory therapy for asthma. LANCET. 351:672-672.
  • Kay AB. (14 Feb 1998). ABC of allergies. Good allergy practice. BMJ. 316:535-537.
  • Kay AB. (14 Feb 1998). Good allergy practice. BRIT MED J. 316:535-537.
  • Ying S; Barata LT; Meng Q; Grant JA; Barkans J; Durham SR; Kay AB. (Feb 1998). High-affinity immunoglobulin E receptor (Fc epsilon RI)-bearing eosinophils, mast cells, macrophages and Langerhans' cells in allergen-induced late-phase cutaneous reactions in atopic subjects. Immunology. 93:281-288.
  • Barata LT; Ying S; Meng Q; Barkans J; Rajakulasingam K; Durham SR; Kay AB. (Feb 1998). IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Allergy Clin Immunol. 101:222-230.
  • Haselden BM; Larche M; Barata LT; Robinson DS; Kay AB. (Jan 1998). Asthma provoked by T-cell peptide epitopes. J ALLERGY CLIN IMMUN. 101:S146-S146.
  • Smith SJ; Sihra BS; Kon OM; Barkans J; Larche M; Levi-Schaffer F; Kay AB. (Jan 1998). In vitro up-regulation of Fc epsilon RI on human peripheral blood eosinophils from atopic subjects. J ALLERGY CLIN IMMUN. 101:S96-S96.
  • Durham SR; Ying S; Meng Q; Humbert M; Gould H; Kay AB. (Jan 1998). Local expression of germline gene transcripts (I epsilon) and RNA for the heavy chain IgE (C epsilon) in the bronchial mucosa in atopic and non-atopic asthma. J ALLERGY CLIN IMMUN. 101:S162-S162.
  • Syrigou E; Haselden BM; Bungre J; Kay AB; Larche M. (Jan 1998). Mapping of T cell epitopes of chain 1 Fel d 1 by primary peripheral blood mononuclear cell proliferation assays in cat allergic asthmatics, cat allergic rhinitics, non cat allergic asthmatics and normal controls. J ALLERGY CLIN IMMUN. 101:S142-S143.
  • Kay AB. (1998). Role of T cells in asthma. Chem Immunol. 71:178-191.
  • Bentley A; Ying S; Gaga M; Barkans J; O'Brien F; Humbert M; Kay AB; Durham SR. (Jan 1998). Tissue eosinophilia and increased numbers of cell expressing mRNA for IL-4 and IL-5 occur in asthma but not bronchiectasis. J ALLERGY CLIN IMMUN. 101:S107-S107.
  • Ying S; Robinson DS; Meng Q; Rottman J; Kennedy R; Ringler DJ; Mackay CR; Daugherty BL; et alSpringer MS; Durham SR; Williams TJ; Kay AB. (Dec 1997). Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol. 27:3507-3516. DOI.
  • Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB. (Nov 1997). Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Allergy. 52:1095-1101.
  • Till S; Walker S; Dickason R; Huston D; O'Brien F; Lamb J; Kay AB; Corrigan C; et alDurham S. (Oct 1997). IL-5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis. Clin Exp Immunol. 110:114-121.
  • Humbert M; Corrigan CJ; Kimmitt P; Till SJ; Kay AB; Durham SR. (Sep 1997). Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med. 156:704-708.
  • Rajakulasingam K; Durham SR; O'Brien F; Humbert M; Barata LT; Reece L; Kay AB; Grant JA. (Jul 1997). Enhanced expression of high-affinity IgE receptor (Fc epsilon RI) alpha chain in human allergen-induced rhinitis with co-localization to mast cells, macrophages, eosinophils, and dendritic cells. J Allergy Clin Immunol. 100:78-86.
  • Ying S; Meng Q; Barata LT; Robinson DS; Durham SR; Kay AB. (15 May 1997). Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol. 158:5050-5057.
  • Barata LT; Ying S; Grant JA; Humbert M; Barkans J; Meng Q; Durham SR; Kay AB. (May 1997). Allergen-induced recruitment of Fc epsilon RI+ eosinophils in human atopic skin. Eur J Immunol. 27:1236-1241. DOI.
  • Sihra BS; Kon OM; Durham SR; Walker S; Barnes NC; Kay AB. (May 1997). Effect of cyclosporin A on the allergen-induced late asthmatic reaction. Thorax. 52:447-452.
  • Humbert M; Durham SR; Kimmitt P; Powell N; Assoufi B; Pfister R; Menz G; Kay AB; et alCorrigan CJ. (May 1997). Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol. 99:657-665.
  • Kay AB; Barata L; Meng Q; Durham SR; Ying S. (May 1997). Eosinophils and eosinophil-associated cytokines in allergic inflammation. Int Arch Allergy Immunol. 113:196-199.
  • Sihra BS; Kon OM; Grant JA; Kay AB. (May 1997). Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol. 99:699-706.
  • Till S; Durham S; Dickason R; Huston D; Bungre J; Walker S; Robinson D; Kay AB; et alCorrigan C. (May 1997). IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression. Immunology. 91:53-57.
  • GemouEngesaeth V; Bush A; Kay AB; Hamid Q; Corrigan CJ. (May 1997). Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and 'Th2-type' cytokine mRNA expression. PEDIATRICS. 99:695-703.
  • Kay AB. (May 1997). The life and work of Jack Pepys. Clin Exp Allergy. 27 Suppl 1:1-3.
  • Kotsimbos ATC; Humbert M; Minshall E; Durham S; Pfister R; Menz G; Tavernier J; Kay AB; et alHamid Q. (May 1997). Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma. J ALLERGY CLIN IMMUN. 99:666-672.
  • Ying S; Humbert M; Barkans J; Corrigan CJ; Pfister R; Menz G; Larché M; Robinson DS; et alDurham SR; Kay AB. (1 Apr 1997). Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol. 158:3539-3544.
  • Till S; Dickason R; Huston D; Humbert M; Robinson D; Larché M; Durham S; Kay AB; et alCorrigan C. (Apr 1997). IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease. J Allergy Clin Immunol. 99:563-569.
  • Yasruel Z; Humbert M; Kotsimbos TC; Ploysongsang Y; Minshall E; Durham SR; Pfister R; Menz G; et alTavernier J; Kay AB; Hamid Q. (Apr 1997). Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. AM J RESP CRIT CARE. 155:1413-1418.
  • Ying S; Meng Q; Taborda-Barata L; Kay AB. (Jan 1997). Association of apoptosis of neutrophils and eosinophils and their ingestion by macrophages with resolution of the allergen-induced cutaneous late-phase response in atopic human subjects. Proc Assoc Am Physicians. 109:42-50.
  • Humbert M; Ying S; Corrigan C; Menz G; Barkans J; Pfister R; Meng Q; Van Damme J; et alOpdenakker G; Durham SR; Kay AB. (Jan 1997). Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3. Am J Respir Cell Mol Biol. 16:1-8.
  • Larche M; Till SJ; Kay AB; Robinson DS. (Jan 1997). Bronchoalveolar lavage macrophages from atopic asthmatics, but not normal subjects, display CD86-dependent antigen presenting cell function, although CD86 is equally expressed by asthmatic and control macrophages. J ALLERGY CLIN IMMUN. 99:493-493.
  • Meng Q; Ying S; Iversen P; Lopez AF; Kay AB; Robinson DS. (Jan 1997). E21R, a mutant of human granulocyte-macrophage colony-stimulating factor (GM-CSF), selectively inhibits GM-CSF-enhanced eosinophil degranulation. J ALLERGY CLIN IMMUN. 99:497-497.
  • Ying S; Humbert M; Barkans J; Corrigan CJ; Durham SR; Pfister R; Menz G; Robinson DR; et alLarche M; Kay AB. (Jan 1997). Expression of IL-4 and IL-5 mRNA and protein product by CD4(+) and CD8(+) T cells, eosinophils (Eos) and mast cells in bronchial mucosa of atopic (AA) and non-atopic (NAA) asthmatics. J ALLERGY CLIN IMMUN. 99:508-508.
  • Grant JA; Humbert M; TabordaBarata L; Sihra BS; Kon OM; Rajakulasingam K; Durham SR; Kay AB. (1997). High-affinity IgE receptor fc epsilon RI expression in allergic reactions. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY. 113:376-378.
  • Kay AB; Meng Q; Barata LT; Robinson DS; Durham SR; Ying S. (Jan 1997). Kinetics of expression of IL-13 mRNA/protein product and possible role in infiltration of inflammatory cells in allergen-induced human cutaneous late phase response (LPR). J ALLERGY CLIN IMMUN. 99:683-683.
  • Barata LT; Ying S; Grant JA; Barkans J; Meng Q; Humbert M; Durham SR; Kay AB. (Jan 1997). Recruitment of Fc epsilon RI-positive eosinophils in allergen-induced cutaneous late phase response. J ALLERGY CLIN IMMUN. 99:1080-1080.
  • Barkans J; Barata LT; Meng Q; Rajakulasingam K; Durham SR; Kay AB; Ying S. (Jan 1997). Recruitment of interleukin-4 (IL-4) and IL-5 mRNA and protein product positive cells during allergen-induced cutaneous late-phase reactions (LPR) in atopic subjects. J ALLERGY CLIN IMMUN. 99:682-682.
  • Kay AB. Chadwick DJ (ed); Cardew G (ed). (1997). T cells as orchestrators of the asthmatic response. RISING TRENDS IN ASTHMA. 206:56-70.
  • Powell N; Humbert M; Durham SR; Assoufi B; Kay AB; Corrigan CJ. (Dec 1996). Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur Respir J. 9:2454-2460.
  • Humbert M; Durham SR; Ying S; Kimmitt P; Barkans J; Assoufi B; Pfister R; Menz G; et alRobinson DS; Kay AB; Corrigan CJ. (Nov 1996). IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med. 154:1497-1504.
  • Kay AB. (31 Oct 1996). TH2-type cytokines in asthma. Ann N Y Acad Sci. 796:1-8.
  • Corrigan CJ; Bungre JK; Assoufi B; Cooper AE; Seddon H; Kay AB. (Oct 1996). Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents. Eur Respir J. 9:2077-2086.
  • Kay AB. (Aug 1996). Pathology of mild, severe, and fatal asthma. Am J Respir Crit Care Med. 154:S66-S69.
  • Corrigan CJ; Kay AB. (Aug 1996). T-cell/eosinophil interactions in the induction of asthma. Eur Respir J Suppl. 22:72s-78s.
  • Humbert M; Robinson DS; Assoufi B; Kay AB; Durham SR. (Jul 1996). Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks. Thorax. 51:664-669.
  • Durham SR; Ying S; Varney VA; Jacobson MR; Sudderick RM; Mackay IS; Kay AB; Hamid QA. (Jun 1996). Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma. J Allergy Clin Immunol. 97:1356-1365.
  • Humbert M; Grant JA; Taborda-Barata L; Durham SR; Pfister R; Menz G; Barkans J; Ying S; et alKay AB. (Jun 1996). High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma. Am J Respir Crit Care Med. 153:1931-1937.
  • Lock SH; Kay AB; Barnes NC. (Feb 1996). Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med. 153:509-514.
  • Robinson DS; Tsicopoulos A; Meng Q; Durham S; Kay AB; Hamid Q. (Feb 1996). Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol. 14:113-117.
  • Bentley AM; Hamid Q; Robinson DS; Schotman E; Meng Q; Assoufi B; Kay AB; Durham SR. (Feb 1996). Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med. 153:551-556.
  • Ying S; Meng Q; Taborda-Barata L; Corrigan CJ; Barkans J; Assoufi B; Moqbel R; Durham SR; et alKay AB. (Jan 1996). Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol. 26:70-76. DOI.
  • Levi-Schaffer F; Barkans J; Newman TM; Ying S; Wakelin M; Hohenstein R; Barak V; Lacy P; et alKay AB; Moqbel R. (Jan 1996). Identification of interleukin-2 in human peripheral blood eosinophils. Immunology. 87:155-161.
  • Robinson DS; Kay AB. (1996). Role of Th1 and Th2 cells in human allergic disorders. Chem Immunol. 63:187-203.
  • Moqbel R; Ying S; Barkans J; Newman TM; Kimmitt P; Wakelin M; Taborda-Barata L; Meng Q; et alCorrigan CJ; Durham SR; Kay AB. (15 Nov 1995). Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol. 155:4939-4947.
  • Robinson DS; Assoufi B; Durham SR; Kay AB. (Nov 1995). Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy. 25:1118-1127.
  • Till S; Li B; Durham S; Humbert M; Assoufi B; Huston D; Dickason R; Jeannin P; et alKay AB; Corrigan C. (Oct 1995). Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls. Eur J Immunol. 25:2727-2731. DOI.
  • Haczku A; Chung KF; Sun J; Barnes PJ; Kay AB; Moqbel R. (Aug 1995). Airway hyperresponsiveness, elevation of serum-specific IgE and activation of T cells following allergen exposure in sensitized Brown-Norway rats. Immunology. 85:598-603.
  • Haczku A; Moqbel R; Jacobson M; Kay AB; Barnes PJ; Chung KF. (Aug 1995). T-cells subsets and activation in bronchial mucosa of sensitized Brown-Norway rats after single allergen exposure. Immunology. 85:591-597.
  • Levi-Schaffer F; Lacy P; Severs NJ; Newman TM; North J; Gomperts B; Kay AB; Moqbel R. (1 May 1995). Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood. 85:2579-2586.
  • Durham SR; Kay AB; Hamid Q. (May 1995). Changes in allergic inflammation associated with successful immunotherapy. Int Arch Allergy Immunol. 107:282-284.
  • Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB. (May 1995). Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Am J Respir Cell Mol Biol. 12:567-578.
  • Ying S; Durham SR; Corrigan CJ; Hamid Q; Kay AB. (May 1995). Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol. 12:477-487.
  • Kay AB; Ying S; Durham SR. (May 1995). Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reactions. Int Arch Allergy Immunol. 107:208-210.
  • Moqbel R; Levi-Schaffer F; Kay AB. (Dec 1994). Cytokine generation by eosinophils. J Allergy Clin Immunol. 94:1183-1188.
  • Alexander AG; Barkans J; Moqbel R; Barnes NC; Kay AB; Corrigan CJ. (Dec 1994). Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma. Thorax. 49:1231-1233.
  • Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; et alDurham SR. (Oct 1994). Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy. 24:930-939.
  • GEMOUENGESAETH V; BUSH A; KAY AB; CORRIGAN CJ. (Oct 1994). INHALED GLUCOCORTICOID (IGC) THERAPY IN CHILDHOOD ASTHMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT AND REDUCED NUMBERS OF ACTIVATED CD4 AND CD8 PERIPHERAL-BLOOD T-LYMPHOCYTES (PBTLC). CLIN EXP ALLERGY. 24:992-992.
  • TSICOPOULOS A; HAMID Q; HACZKU A; JACOBSON MR; DURHAM SR; NORTH J; BARKANS J; CORRIGAN CJ; et alMENG Q; MOQBEL R; KAY AB. (Oct 1994). KINETICS OF CELL INFILTRATION AND CYTOKINE MESSENGER-RNA EXPRESSION AFTER INTRADERMAL CHALLENGE WITH ALLERGEN AND TUBERCULIN IN THE SAME ATOPIC INDIVIDUALS. J ALLERGY CLIN IMMUN. 94:764-772.
  • Bentley AM; Durham SR; Kay AB. (Sep 1994). Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Investig Allergol Clin Immunol. 4:222-232.
  • Doi S; Gemou-Engesaeth V; Kay AB; Corrigan CJ. (Sep 1994). Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy. Clin Exp Allergy. 24:854-867.
  • Haczku A; Moqbel R; Elwood W; Sun J; Kay AB; Barnes PJ; Chung KF. (Jul 1994). Effects of prolonged repeated exposure to ovalbumin in sensitized brown Norway rats. Am J Respir Crit Care Med. 150:23-27.
  • Robinson DS; Ying S; Taylor IK; Wangoo A; Mitchell DM; Kay AB; Hamid Q; Shaw RJ. (Apr 1994). Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am J Respir Crit Care Med. 149:989-993.
  • KAY AB. (24 Feb 1994). ORIGIN OF TYPE-2 HELPER T-CELLS. NEW ENGL J MED. 330:567-569.
  • DURHAM SR; VARNEY VA; SUN Y; JACOBSON MR; SUDDERICK RM; MACKAY IS; KAY AB; HAMID Q. (Jan 1994). EFFECT OF GRASS-POLLEN IMMUNOTHERAPY ON CELL INFILTRATION AND CYTOKINE MESSENGER-RNA EXPRESSION DURING ALLERGEN-INDUCED LATE NASAL RESPONSES. J ALLERGY CLIN IMMUN. 93:230-230.
  • GEMOUENGESAETH V; BUSH A; KAY AB; CORRIGAN CJ. (Jan 1994). INHALED GLUCOCORTICOID (IGC) THERAPY IN CHILDHOOD ASTHMA IS ASSOCIATED WITH CLINICAL IMPROVEMENT AND REDUCED NUMBERS OF ACTIVATED CD4 AND CD8 PERIPHERAL-BLOOD T-LYMPHOCYTES (PBTLC). J ALLERGY CLIN IMMUN. 93:197-197.
  • Bentley AM; Durham SR; Robinson DS; Menz G; Storz C; Cromwell O; Kay AB; Wardlaw AJ. (Dec 1993). Expression of endothelial and leukocyte adhesion molecules interacellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma. J Allergy Clin Immunol. 92:857-868.
  • Sehmi R; Cromwell O; Wardlaw AJ; Moqbel R; Kay AB. (Dec 1993). Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy. 23:1027-1036.
  • Hartnell A; Robinson DS; Kay AB; Wardlaw AJ. (Oct 1993). CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology. 80:281-286.
  • Ying S; Durham SR; Barkans J; Masuyama K; Jacobson M; Rak S; Löwhagen O; Moqbel R; et alKay AB; Hamid QA. (Oct 1993). T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol. 9:356-360.
  • Robinson DS; Ying S; Bentley AM; Meng Q; North J; Durham SR; Kay AB; Hamid Q. (Sep 1993). Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol. 92:397-403.
  • Robinson D; Hamid Q; Bentley A; Ying S; Kay AB; Durham SR. (Aug 1993). Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol. 92:313-324.
  • Robinson DS; Durham SR; Kay AB. (Aug 1993). Cytokines. 3. Cytokines in asthma. Thorax. 48:845-853.
  • Robinson D; Hamid Q; Ying S; Bentley A; Assoufi B; Durham S; Kay AB. (Aug 1993). Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression. Am Rev Respir Dis. 148:401-406.
  • ALEXANDER AG; CORRIGAN CJ; JARDIEU P; BARNES NC; KAY AB. (Apr 1993). CLINICAL-RESPONSE TO CYCLOSPORINE-A THERAPY IN CHRONIC SEVERE ASTHMA IS ASSOCIATED WITH A DECREASE IN SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR (IL-2R). AM REV RESPIR DIS. 147:A981-A981.
  • ROBINSON DS; YING S; TAYLOR I; WANGOO A; KAY AB; HAMID Q; SHAW RJ. (Apr 1993). EVIDENCE OF TH1 T-CELL CYTOKINE MESSENGER-RNA EXPRESSION BY BRONCHOALVEOLAR CELLS IN PULMONARY TUBERCULOSIS. AM REV RESPIR DIS. 147:A467-A467.
  • Anwar AR; Moqbel R; Walsh GM; Kay AB; Wardlaw AJ. (1 Mar 1993). Adhesion to fibronectin prolongs eosinophil survival. J Exp Med. 177:839-843.
  • Corrigan CJ; Haczku A; Gemou-Engesaeth V; Doi S; Kikuchi Y; Takatsu K; Durham SR; Kay AB. (Mar 1993). CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis. 147:540-547.
  • ALEXANDER AG; CORRIGAN CJ; ABRAMS J; BARNES NC; KAY AB. (Feb 1993). IN-VITRO T-LYMPHOCYTE FUNCTION AND CYTOKINE PRODUCTION IN CHRONIC SEVERE ASTHMA - EFFECTS OF DEXAMETHASONE AND CYCLOSPORINE-A. CLIN EXP ALLERGY. 23:75-75.
  • Kay AB. (9 Jan 1993). Alternative allergy and the General Medical Council. BMJ. 306:122-124.
  • Robinson DS; Bentley AM; Hartnell A; Kay AB; Durham SR. (Jan 1993). Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax. 48:26-32.
  • Robinson DS; Hamid Q; Jacobson M; Ying S; Kay AB; Durham SR. (1993). Evidence for Th2-type T helper cell control of allergic disease in vivo. Springer Semin Immunopathol. 15:17-27.
  • Sehmi R; Walsh GM; Hartnell A; Barkans J; North J; Kay AB; Moqbel R. (1993). Modulation of human eosinophil chemotaxis and adhesion by anti-allergic drugs in vitro. Pediatr Allergy Immunol. 4:13-18.
  • Hartnell A; Kay AB; Wardlaw AJ. (Dec 1992). Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone. Immunology. 77:488-493.
  • Corrigan CJ; Kay AB. (Dec 1992). T cells and eosinophils in the pathogenesis of asthma. Immunol Today. 13:501-507.
  • Cromwell O; Hamid Q; Corrigan CJ; Barkans J; Meng Q; Collins PD; Kay AB. (Nov 1992). Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology. 77:330-337.
  • Sehmi R; Rossi AG; Kay AB; Cromwell O. (Sep 1992). Identification on receptors for leukotriene B4 expressed on guinea-pig peritoneal eosinophils. Immunology. 77:129-135.
  • DHILLON DP; WINTER J; MORGAN MDL; WARDLAW AJ; TREACHER DF; WOODCOCK A; MOOREGILLON JC; CORRIS P; et alWEDZICHA JA; BARNES NC; RUDD RM; IND PW; AYRES JG; DURHAM SR; DUBOIS RM; KAY AB; MCLEOD DT; MITCHELL D; FITZHARRIS P; WINTER RJD; BRITTON J; KNOX A; DOUGLAS JG; WOODHEAD MA; TWORT CHC; HARVEY J; MILLAR A. (15 Aug 1992). RESPIRATORY MEDICINE - FIGHTING FOR SURVIVAL. BRIT MED J. 305:427-427.
  • Varney VA; Jacobson MR; Sudderick RM; Robinson DS; Irani AM; Schwartz LB; Mackay IS; Kay AB; et alDurham SR. (Jul 1992). Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis. 146:170-176.
  • Sehmi R; Wardlaw AJ; Cromwell O; Kurihara K; Waltmann P; Kay AB. (1 Jun 1992). Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood. 79:2952-2959.
  • Azzawi M; Johnston PW; Majumdar S; Kay AB; Jeffery PK. (Jun 1992). T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis. 145:1477-1482.
  • DURHAM SR; YING S; VARNEY VA; JACOBSON MR; SUDDERICK RM; MACKAY IS; KAY AB; HAMID QA. (15 Apr 1992). CYTOKINE MESSENGER-RNA EXPRESSION FOR IL-3, IL-4, IL-5, AND GRANULOCYTE/MACROPHAGE-COLONY-STIMULATING FACTOR IN THE NASAL-MUCOSA AFTER LOCAL ALLERGEN PROVOCATION - RELATIONSHIP TO TISSUE EOSINOPHILIA. J IMMUNOL. 148:2390-2394.
  • Hamid Q; Barkans J; Robinson DS; Durham SR; Kay AB. (Apr 1992). Co-expression of CD25 and CD3 in atopic allergy and asthma. Immunology. 75:659-663.
  • Bentley AM; Jacobson MR; Cumberworth V; Barkans JR; Moqbel R; Schwartz LB; Irani AM; Kay AB; et alDurham SR. (Apr 1992). Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol. 89:877-883.
  • Tsicopoulos A; Hamid Q; Varney V; Ying S; Moqbel R; Durham SR; Kay AB. (1 Apr 1992). Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol. 148:2058-2061.
  • Madden BP; Hodson ME; Yacoub MH; Alton EW; Barnes PJ; Denison DM; Kay AB; Newman-Taylor A; et alGeddes DM. (28 Mar 1992). Heart-lung transplantation for cystic fibrosis. BMJ. 304:835-836.
  • MADDEN BP; HODSON ME; YACOUB MH; ALTON EWFW; BARNES PJ; DENISON DM; KAY AB; NEWMANTAYLOR A; et alGEDDES DM; CHUNG KF. (28 Mar 1992). ROYAL-BROMPTON GRAND ROUNDS - HEART-LUNG TRANSPLANTATION FOR CYSTIC-FIBROSIS. BRIT MED J. 304:835-836.
  • Hartnell A; Kay AB; Wardlaw AJ. (1 Mar 1992). IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. J Immunol. 148:1471-1478.
  • Alexander AG; Barnes NC; Kay AB. (8 Feb 1992). Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet. 339:324-328.
  • Moqbel R; Barkans J; Bradley BL; Durham SR; Kay AB. (Feb 1992). Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy. 22:265-273.
  • Robinson DS; Hamid Q; Ying S; Tsicopoulos A; Barkans J; Bentley AM; Corrigan C; Durham SR; et alKay AB. (30 Jan 1992). Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 326:298-304. DOI.
  • Corrigan CJ; Kay AB. (Jan 1992). Asthma. Role of T-lymphocytes and lymphokines. Br Med Bull. 48:72-84.
  • Varney V; Gaga M; Frew AJ; De Vos C; Kay AB. (Jan 1992). The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects. Clin Exp Allergy. 22:43-49.
  • Corrigan CJ; Brown PH; Barnes NC; Szefler SJ; Tsai JJ; Frew AJ; Kay AB. (Nov 1991). Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis. 144:1016-1025.
  • Corrigan CJ; Brown PH; Barnes NC; Tsai JJ; Frew AJ; Kay AB. (Nov 1991). Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A. Am Rev Respir Dis. 144:1026-1032.
  • Ying S; Robinson DS; Varney V; Meng Q; Tsicopoulos A; Moqbel R; Durham SR; Kay AB; et alHamid Q. (Nov 1991). TNF alpha mRNA expression in allergic inflammation. Clin Exp Allergy. 21:745-750.
  • BRADLEY BL; AZZAWI M; JACOBSON M; ASSOUFI B; COLLINS JV; IRANI AMA; SCHWARTZ LB; DURHAM SR; et alJEFFERY PK; KAY AB. (Oct 1991). EOSINOPHILS, T-LYMPHOCYTES, MAST-CELLS, NEUTROPHILS, AND MACROPHAGES IN BRONCHIAL BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITH ASTHMA - COMPARISON WITH BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITHOUT ASTHMA AND NORMAL CONTROL SUBJECTS AND RELATIONSHIP TO BRONCHIAL HYPERRESPONSIVENESS. J ALLERGY CLIN IMMUN. 88:661-674.
  • Sehmi R; Cromwell O; Taylor GW; Kay AB. (1 Oct 1991). Identification of guinea pig eosinophil chemotactic factor of anaphylaxis as leukotriene B4 and 8(S),15(S)-dihydroxy-5,9,11,13(Z,E,Z,E)-eicosatetraenoic acid. J Immunol. 147:2276-2283.
  • Faccioli LH; Nourshargh S; Moqbel R; Williams FM; Sehmi R; Kay AB; Williams TJ. (Jun 1991). The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology. 73:222-227.
  • Walsh GM; Mermod JJ; Hartnell A; Kay AB; Wardlaw AJ. (15 May 1991). Human eosinophil, but not neutrophil, adherence to IL-1-stimulated human umbilical vascular endothelial cells is alpha 4 beta 1 (very late antigen-4) dependent. J Immunol. 146:3419-3423.
  • Kay AB. (May 1991). Biological properties of eosinophils. Clin Exp Allergy. 21 Suppl 3:23-29.
  • HAMID Q; AZZAWI M; YING S; MOQBEL R; WARDLAW AJ; CORRIGAN CJ; BRADLEY B; DURHAM SR; et alCOLLINS JV; JEFFERY PK; QUINT DJ; KAY AB. (May 1991). EXPRESSION OF MESSENGER-RNA FOR INTERLEUKIN-5 IN MUCOSAL BRONCHIAL BIOPSIES FROM ASTHMA. J CLIN INVEST. 87:1541-1546.
  • Moqbel R; Hartnell A; Kay AB. (May 1991). The effects of picumast on human eosinophil and neutrophil activation. Clin Exp Allergy. 21 Suppl 3:39-44.
  • Frew AJ; Kay AB. (May 1991). UCHL1+ (CD45RO+) 'memory' T cells predominate in the CD4+ cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects. Clin Exp Immunol. 84:270-274.
  • KAY AB; VARNEY VA; DURHAM SR. (2 Mar 1991). IMMUNOTHERAPY AND HAY-FEVER - REPLY. BRIT MED J. 302:531-531.
  • Kay AB. (Mar 1991). Lymphocytes in asthma. Respir Med. 85:87-90.
  • Varney VA; Gaga M; Frew AJ; Aber VR; Kay AB; Durham SR. (2 Feb 1991). Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ. 302:265-269.
  • Corrigan CJ; Kay AB. (1991). CD4 T lymphocyte activation in acute severe asthma. Int Arch Allergy Appl Immunol. 94:270-271.
  • Walsh GM; Moqbel R; Hartnell A; Kay AB. (1991). Effects of cetirizine on human eosinophil and neutrophil activation in vitro. Int Arch Allergy Appl Immunol. 95:158-162.
  • Frew AJ; Varney VA; Gaga M; Kay AB. (1991). Immunohistology of human allergic late-phase skin reactions. Skin Pharmacol. 4 Suppl 1:71-78.
  • Walsh GM; Wardlaw AJ; Hartnell A; Sanderson CJ; Kay AB. (1991). Interleukin-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Int Arch Allergy Appl Immunol. 94:174-178.
  • HAMID Q; AZZAWI M; YING S; MOQBEL R; WARDLAW AJ; CORRIGAN CJ; BRADLEY B; DURHAM SR; et alCOLLINS JV; JEFFERY PK; QUINT DJ; KAY AB. (1991). INTERLEUKIN-5 MESSENGER-RNA IN MUCOSAL BRONCHIAL BIOPSIES FROM ASTHMATIC SUBJECTS. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY. 94:169-170.
  • Kay AB. (1991). T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol. 94:189-193.
  • Azzawi M; Bradley B; Jeffery PK; Frew AJ; Wardlaw AJ; Knowles G; Assoufi B; Collins JV; et alDurham S; Kay AB. (Dec 1990). Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis. 142:1407-1413.
  • Cromwell O; Wardlaw AJ; Champion A; Moqbel R; Osei D; Kay AB. (1 Dec 1990). IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils. J Immunol. 145:3862-3868.
  • Heard BE; Dewar A; Nunn AJ; Kay AB. (Jul 1990). Heterogeneous ultrastructure of human bronchial mast cells: morphometric subdivision of cell types and evidence for a degranulation gradient. Am J Respir Cell Mol Biol. 3:71-78.
  • Walsh GM; Hartnell A; Moqbel R; Cromwell O; Nagy L; Bradley B; Furitsu T; Ishizaka T; et alKay AB. (1 Jul 1990). Receptor expression and functional status of cultured human eosinophils derived from umbilical cord blood mononuclear cells. Blood. 76:105-111.
  • Corrigan CJ; Kay AB. (Apr 1990). CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis. 141:970-977.
  • Frew AJ; Kay AB. (Mar 1990). Eosinophils and T-lymphocytes in late-phase allergic reactions. J Allergy Clin Immunol. 85:533-539.
  • Hartnell A; Moqbel R; Walsh GM; Bradley B; Kay AB. (Feb 1990). Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophils. Immunology. 69:264-270.
  • Frew AJ; Moqbel R; Azzawi M; Hartnell A; Barkans J; Jeffery PK; Kay AB; Scheper RJ; et alVarley J; Church MK. (Feb 1990). T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pig. Am Rev Respir Dis. 141:407-413.
  • Walsh GM; Moqbel R; Nagakura T; Iikura Y; Kay AB. (1990). Enhancement of the expression of eosinophil IgE receptor (Fc epsilon R2) and its function by platelet-activating factor. J Lipid Mediat. 2 Suppl:S177-S186.
  • Jeffery PK; Wardlaw AJ; Nelson FC; Collins JV; Kay AB. (Dec 1989). Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis. 140:1745-1753.
  • Lamb JR; Kay AB; O'Hehir RE. (Jul 1989). HLA class II restriction specificity of Dermatophagoides spp. reactive T lymphocyte clones that support IgE synthesis. Clin Exp Allergy. 19:389-393.
  • O'Hehir RE; Bal V; Quint D; Moqbel R; Kay AB; Zanders ED; Lamb JR. (Apr 1989). An in vitro model of allergen-dependent IgE synthesis by human B lymphocytes: comparison of the response of an atopic and a non-atopic individual to Dermatophagoides spp. (house dust mite). Immunology. 66:499-504.
  • Tsai JJ; Cromwell O; Maestrelli P; O'Hehir RE; Moqbel R; Kay AB. (1 Mar 1989). Leukotriene release enhancing factor. Purification, specific allergen induction, and further biologic properties. J Immunol. 142:1661-1668.
  • Kay AB. (1989). Cell-mediated immune response in asthma. Agents Actions Suppl. 28:365-373.
  • OHEHIR R; YOUNG D; KAY AB; LAMB J. (Jan 1989). CLONAL ANALYSIS OF THE CELLULAR IMMUNE-RESPONSE TO THE HOUSE DUST MITE DERMATOPHAGOIDES-FARINAE. INT ARCH ALLER A IMM. 88:170-172.
  • Kay AB. (1989). Inflammatory cells in chronic asthma. Agents Actions Suppl. 28:147-161.
  • Kay AB; Frew AJ; Moqbel R; Walsh GM; Kurihara K; Cromwell O; Champion A; Hartnell A; et alWardlaw AJ. (1989). The activated eosinophil in allergy and asthma. Prog Clin Biol Res. 297:183-196.
  • Moqbel R; Cromwell O; Kay AB. (1989). The effect of nedocromil sodium on human eosinophil activation. Drugs. 37 Suppl 1:19-22.
  • Maestrelli P; O'Hehir RE; Lamb JR; Tsai JJ; Cromwell O; Kay AB. (Dec 1988). Antigen-induced neutrophil chemotactic factor from cloned human T lymphocytes. Immunology. 65:605-609.
  • Tsai JJ; Maestrelli P; Cromwell O; Moqbel R; Fitzharris P; Kay AB. (Nov 1988). A T-lymphocyte-derived factor that enhances IgG-dependent release of leukotriene B4 (LTB4) from human neutrophils. Immunology. 65:449-456.
  • OHEHIR RE; ECKELS DD; FREW AJ; KAY AB; LAMB JR. (Aug 1988). MHC CLASS-II RESTRICTION SPECIFICITY OF CLONED HUMAN LYMPHOCYTES-T REACTIVE WITH DERMATOPHAGOIDES-FARINAE (HOUSE DUST MITE). IMMUNOLOGY. 64:627-631.
  • OHEHIR RE; BAL V; QUINT D; MOQBEL R; KAY AB; ZANDERS E; LAMB J. (20 Mar 1988). IGE INDUCTION BY HUMAN CLONED LYMPHOCYTES-T SPECIFIC FOR HOUSE DUST MITE IS IL-4 DEPENDENT. FASEB J. 2:A1442-A1442.
  • OHEHIR RE; YOUNG DB; KAY AB; LAMB JR. (Dec 1987). CLONED HUMAN LYMPHOCYTES-T REACTIVE WITH DERMATOPHAGOIDES-FARINAE (HOUSE DUST MITE) - A COMPARISON OF T-CELL AND B-CELL ANTIGEN RECOGNITION. IMMUNOLOGY. 62:635-640.
  • MOQBEL R; RICHERSON HB; MACDONALD AJ; WALSH GM; HARTNELL A; WALPORT MJ; KAY AB. (Sep 1987). CHEMOTACTIC FACTOR-INDUCED LOW-DENSITY NEUTROPHILS EXPRESS ENHANCED COMPLEMENT (CR-1 AND CR3) RECEPTORS AND INCREASED COMPLEMENT-DEPENDENT CYTOTOXICITY. CLIN EXP IMMUNOL. 69:676-686.
  • OHEHIR RE; LAMB JR; KAY AB. (Sep 1987). HUMAN T-CELL LINES AND CLONES SPECIFIC FOR THE HOUSE DUST MITE DERMATOPHAGOIDES-FARINAE - A TOOL FOR RESEARCH IN ASTHMA AND RHINITIS. THORAX. 42:710-710.
  • SHAW RJ; WALSH GM; CROMWELL O; MOQBEL R; SPRY CJF; KAY AB. (1985). ACTIVATED HUMAN EOSINOPHILS GENERATE SRS-A LEUKOTRIENES FOLLOWING IGG-DEPENDENT STIMULATION. NATURE. 316:150-152.
  • LEE TH; NAGAKURA T; CROMWELL O; BROWN MJ; CAUSON R; KAY AB. (1984). NEUTROPHIL CHEMOTACTIC ACTIVITY AND HISTAMINE IN ATOPIC AND NONATOPIC SUBJECTS AFTER EXERCISE-INDUCED ASTHMA. AM REV RESPIR DIS. 129:409-412.
  • CROMWELL O; WALPORT MJ; TAYLOR GW; MORRIS HR; ODRISCOLL BRC; KAY AB. (1982). IDENTIFICATION OF LEUKOTRIENES IN THE SPUTUM OF PATIENTS WITH CYSTIC-FIBROSIS. ADV PROSTAG THROMB L. 9:251-257.
  • CROMWELL O; MORRIS HR; HODSON ME; WALPORT MJ; TAYLOR GW; BATTEN J; KAY AB. (1981). IDENTIFICATION OF LEUKOTRIENE-D AND LEUKOTRIENE-B IN SPUTUM FROM CYSTIC-FIBROSIS PATIENTS. LANCET. 2:164-165.
  • KAY AB; PEPPER DS; EWART MR. (1973). GENERATION OF CHEMOTACTIC ACTIVITY FOR LEUKOCYTES BY ACTION OF THROMBIN ON HUMAN FIBRINOGEN. NATURE-NEW BIOL. 243:56-57.

Books

  • A.B. Kay (editor). Allergy and allergic diseases: with a view to the future. Br Med Bull 56. Royal Society of Medicine Press Limited, London (2000).
  • G. Marone; K.F. Austen; S.T. Holgate; A.B. Kay; L.M. Lichtenstein (editors). Asthma and Allergic Diseases. Physiology, Immunopharmacology and Treatment. 1-439. Academic Press, London (1998).
  • A.B. Kay (editor). Kay AB (ed). Allergy and Allergic Diseases. 1st, volumes 1 and 2:1-1738. Blackwell Science, Oxford (1997).

Conferences

  • Kay AB; Bonner K; Kariyawasam HH; Ali FR; Clark P. EXPRESSION OF FUNCTIONAL RECEPTOR ACTIVITY MODIFYING PROTEIN (RAMP)-1 BY AIRWAY EPITHELIAL CELLS WITH DYSREGULATION IN ASTHMA. 65:A21-A21. (Dec 2010). DOI.
  • Ong YE; Menzies-Gov A; Kay AB. The effects of omalizumab (humanized monoclonal anti-immunoglobulin E antibody) on allergen-induced markers of inflammation in the skin of atopic subjects. 34:1807-1807. (Nov 2004).
  • Menz G; Ying S; Durham SR; Corrigan CJ; Rohinson DS; Hamid Q; Pfister R; Humbert M; et alKay AB. Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma. 53:15-21. (1998).

Patents

  • "Cryptic Peptides" PCT/GB97/00783 (priority date 21 Mar 1996). Larche M.
  • "Methods for Desensitisation" WO/99/34826 (priority date 9 Jan 1998). Larche M.
Share this on DeliciousTweet thisDigg thisStumble thisShare this on Facebook